Skip to content

Topical effect of cicer arientinumr extract on some clinical signs of knee osteoarthritis

Topical effect of cicer arientinumr extract on some clinical signs of knee osteoarthritis: a randomized and double blind clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181030041500N1
Enrollment
75
Registered
2019-04-30
Start date
2017-09-23
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: Group B: topically received cicer arientinumr extraction twice a day for three months. Patients in all three groups can use oral drugs to relieve pain in the same

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diagnosis of knee osteoarthritis according to the American College of Rheumatology criteria, which approved by Rheumatologist The presence of moderate knee pain within 24 hours based on the linear-visual pain scale (VAS) between 4 to 7 cm 2 Age between 50 to 70 years old

Exclusion criteria

Exclusion criteria: Patients with inflammatory diseases (such as lupus, rheumatoid arthritis, history of brucellosis, etc.), cancer or severe illness Symptoms or history of liver or kidney failure consumption Corton in the last 4 weeks Corton injection over the past 6 months Fever Consumption of herbal medicine continuously Sensitivity to cicer arientinum Unwillingness to continue participating in the study Failure to observe the study protocol See any complications caused by cicer arientinumr Use of food and pharmaceutical supplements daily painkiller consumption Very advanced disease

Design outcomes

Primary

MeasureTime frame
Knee pain level in Visual Analogue Scale. Timepoint: At the beginning and the end of the study (three months after the beginning of the study). Method of measurement: Visual Analogue Scale – VAS.;Western Ontario and Mc Master ( womac ) degree. Timepoint: At the beginning and the end of the study (three months after the beginning of the study). Method of measurement: Western Ontario and Mc Master ( womac ) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPooya Seaad Askari

Rafsanjan University of Medical Sciences

pooyasaeedaskary@gmail.com+98 34 3428 0038

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026